Complete Filing Data
Chicago Atlantic Real Estate Finance, Inc. reported Stockholders Equity of $307.81 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Chicago Atlantic Real Estate Finance, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income * | $36.0M | $37.0M | $38.7M | $32.3M |
| Interest Income Expense Net | $55.4M | $55.0M | $57.1M | $48.9M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $36.0M | $37.0M | $38.7M | $32.3M |
| General And Administrative Expense | $5.3M | $5.4M | $5.3M | $3.5M |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $16.6M | |||
| Interest Expense | $5.8M | $2.6M | ||
| Interest Revenue Expense Net | -$2.6M | |||
| Revenues | $48.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $8.9M | $8.9M | $10.0M | $11.2M | $9.2M | $8.7M | $10.0M | $8.6M | $10.7M | $9.8M | $7.5M | $7.8M | $4.1M | $1.1M |
| Interest Income Expense Net | $13.7M | $14.4M | $13.0M | $14.5M | $13.2M | $13.2M | $13.7M | $13.7M | $14.9M | $12.9M | $11.9M | $9.8M | $4.1M | $1.2M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $8.9M | $8.9M | $10.0M | $11.2M | $9.2M | $8.7M | $10.0M | $8.6M | $10.7M | $9.8M | $7.5M | $7.8M | $4.1M | $1.1M |
| General And Administrative Expense | $1.3M | $1.3M | $1.2M | $1.3M | $1.3M | $1.4M | $1.3M | $1.3M | $1.3M | $1.1M | $777.2K | $556.1K | $13.5K | |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Operating Expenses | $5.0M | $4.2M | $3.2M | $3.9M | $2.0M | $48.6K | $69.2K | |||||||
| Interest Expense | $1.8M | $1.8M | $2.1M | $1.4M | $994.9K | $1.6M | $861.3K | |||||||
| Interest Revenue Expense Net | -$994.9K | -$1.6M | -$861.3K | -$449.6K | -$72.3K | -$25.2K | -$16.7K | |||||||
| Revenues | $13.7M | $14.9M | $12.9M | $11.4M | $9.8M | $4.1M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | $307.8M | $309.0M | $271.9M | $264.0M | $264.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $14.9M | $26.4M | $7.9M | $5.7M | $80.2M |
| Retained Earnings Accumulated Deficit | -$15.5M | -$10.1M | -$5.8M | -$5.1M | -$177.6K |
| Other Receivables | $874.2K | $459.2K | $706.0K | $1.0M | $874.2K |
| Liabilities And Stockholders Equity | $424.9M | $435.1M | $359.2M | $343.3M | $278.2M |
| Liabilities | $117.1M | $126.2M | $87.4M | $79.2M | $14.1M |
| Interest Receivable | $4.0M | $1.5M | $1.0M | $1.2M | $197.7K |
| Common Stock Value | $210.8K | $208.3K | $182.0K | $176.9K | $173.6K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$11.5M | $18.5M | $2.2M | -$74.5M | |
| Cash And Cash Equivalents At Carrying Value | $14.9M | $26.4M | $7.9M | $5.7M | $80.2M |
| Assets | $424.9M | $435.1M | $359.2M | $343.3M | $278.2M |
| Accretion Amortization Of Discounts And Premiums Investments | $2.2M | $1.7M | $3.0M | $2.9M | |
| Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings | $39.5M | $41.0M | $39.4M | $37.3M | |
| Management Fee Payable | $3.2M | $3.3M | $802.3K | ||
| Management And Incentive Fees Payable | $3.1M | $2.9M | $8.8M | $6.6M | |
| Interest Payable Current And Noncurrent | $1.3M | $1.1M | $1.1M | $1.9M | $6.6M |
| Dividends Payable Current And Noncurrent | $11.2M | $13.6M | $13.9M | $13.6M | $4.5M |
| Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Investment | $332.8M | $364.2M | $337.2M | $339.3M | |
| Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss | $409.0M | $402.5M | $353.6M | $339.3M | |
| Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss | $403.9M | $398.1M | $348.7M | $335.3M | |
| Financing Receivable Allowance For Credit Loss Excluding Accrued Interest | $5.1M | $4.3M | $5.0M | $3.9M | |
| Additional Paid In Capital Common Stock | $323.1M | $318.9M | $277.5M | $269.0M | |
| Accounts Payable And Accrued Liabilities Current And Noncurrent | $835.0K | $1.1M | $1.1M | $1.1M | |
| Debt Securities Realized Gain Loss | $0.00 | $72.4K | $104.8K | ||
| Provision For Loan Lease And Other Losses | $940.4K | $3.9M | |||
| Other Liabilities | $2.2M | $2.0M | $2.1M | ||
| Other Assets Current | $1.2M | $3.4M | $107.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $309.9M | $310.0M | $310.8M | $295.5M | $292.7M | $286.0M | $275.8M | $273.7M | $272.1M | $270.2M | $268.6M | $269.4M | $128.7M | $56.4M | $100.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $28.9M | $35.6M | $9.9M | $6.8M | $7.1M | $6.9M | $8.7M | $18.0M | $4.6M | $9.3M | $6.6M | $6.1M | $8.7M | $943.6K | $100.0K | |
| Retained Earnings Accumulated Deficit | -$12.5M | -$11.5M | -$9.9M | -$4.5M | -$6.4M | -$6.1M | -$1.3M | -$2.9M | -$3.0M | $1.1M | -$353.0K | $526.5K | ||||
| Other Receivables | $581.8K | $423.0K | $525.3K | $614.8K | $628.8K | $5.1M | $946.1K | $1.0M | $1.7M | $844.5K | $956.4K | $16.2K | ||||
| Liabilities And Stockholders Equity | $427.1M | $455.2M | $414.7M | $365.9M | $386.5M | $383.7M | $352.3M | $330.6M | $322.9M | $340.5M | $337.6M | $285.9M | ||||
| Liabilities | $117.2M | $145.2M | $103.9M | $70.4M | $93.8M | $97.7M | $76.5M | $56.9M | $50.8M | $70.3M | $68.9M | $16.5M | ||||
| Interest Receivable | $4.5M | $3.3M | $1.5M | $484.4K | $1.2M | $926.9K | $2.2M | $994.8K | $4.2M | $727.3K | $975.6K | $373.7K | ||||
| Common Stock Value | $210.8K | $210.7K | $208.9K | $196.3K | $196.2K | $191.0K | $181.8K | $181.8K | $180.9K | $176.6K | $176.6K | $176.6K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$16.5M | -$993.9K | -$1.1M | -$74.2M | $843.6K | $100.0K | ||||||||||
| Cash And Cash Equivalents At Carrying Value | $28.9M | $35.6M | $9.9M | $6.8M | $7.1M | $6.9M | $8.7M | $18.0M | $4.6M | $9.3M | $6.6M | $6.1M | ||||
| Assets | $427.1M | $455.2M | $414.7M | $365.9M | $386.5M | $383.7M | $352.3M | $330.6M | $322.9M | $340.5M | $337.6M | $285.9M | ||||
| Accretion Amortization Of Discounts And Premiums Investments | $370.0K | $477.8K | $908.9K | $894.1K | $64.1K | |||||||||||
| Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings | $9.9M | $9.9M | $9.8M | $9.2M | $9.2M | $9.0M | $8.4M | $8.6M | $8.5M | $8.3M | ||||||
| Management Fee Payable | $1.9M | $1.7M | $2.9M | $1.7M | $1.8M | $1.8M | $1.6M | $1.8M | $2.1M | $1.3M | $1.2M | $671.5K | ||||
| Management And Incentive Fees Payable | $1.4M | $1.9M | $1.7M | $1.7M | $1.8M | $1.8M | $1.6M | $1.8M | $2.1M | $1.3M | ||||||
| Interest Payable Current And Noncurrent | $14.6K | $243.4K | $547.5K | $2.6M | $2.5M | $2.5M | $498.3K | $342.0K | $220.1K | $5.6M | ||||||
| Dividends Payable Current And Noncurrent | $9.9M | $9.9M | $9.8M | $9.3M | $9.3M | $9.0M | $8.6M | $8.7M | $8.7M | $8.4M | ||||||
| Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Investment | $379.1M | $374.0M | $361.0M | $338.3M | $365.5M | $359.3M | $322.5M | |||||||||
| Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss | $398.1M | $414.0M | $399.5M | $354.7M | $381.9M | $375.8M | $338.8M | |||||||||
| Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss | $393.1M | $409.6M | $396.2M | $350.6M | $376.8M | $370.5M | $333.7M | |||||||||
| Financing Receivable Allowance For Credit Loss Excluding Accrued Interest | $5.0M | $4.4M | $3.3M | $4.1M | $5.1M | $5.4M | $5.1M | |||||||||
| Additional Paid In Capital Common Stock | $322.2M | $321.4M | $320.5M | $299.7M | $298.9M | $291.9M | $276.9M | |||||||||
| Accounts Payable And Accrued Liabilities Current And Noncurrent | $1.1M | $1.4M | $2.5M | $1.4M | $1.5M | $1.3M | $1.2M | |||||||||
| Debt Securities Realized Gain Loss | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $72.4K | ||||||||||
| Provision For Loan Lease And Other Losses | $380.3K | $96.1K | $48.3K | |||||||||||||
| Other Liabilities | $3.1M | $1.9M | $1.6M | $1.6M | $2.0M | $1.8M | ||||||||||
| Other Assets Current | $26.4K | $879.2K | $1.2M | $1.5M | $838.9K | $192.4K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Share Based Compensation | $3.4M | $3.1M | $1.5M | $435.6K |
| Stock Issued During Period Value Share Based Compensation | $3.1M | $1.5M | $448.8K | |
| Proceeds From Issuance Of Common Stock | $1.0M | $39.6M | $7.2M | $4.5M |
| Net Cash Provided By Used In Financing Activities | -$49.0M | $34.6M | -$24.3M | $33.7M |
| Net Cash Provided By Used In Operating Activities | $28.8M | $23.2M | $28.4M | $17.0M |
| Net Cash Provided By Used In Investing Activities | $8.7M | -$39.3M | -$1.9M | -$125.2M |
| Increase Decrease In Accrued Interest Receivable Net | $2.6M | $449.7K | -$200.3K | $1.0M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$316.2K | $509.8K | $168.6K | $764.2K |
| Payments Of Stock Issuance Costs | $160.7K | $1.2M | $284.6K | $124.5K |
| Payments Of Dividends | $43.8M | $41.6M | $39.1M | $28.2M |
| Increase Decrease In Other Receivables | $473.5K | -$185.3K | $51.4K | $106.1K |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $235.4K | -$380.6K | -$51.8K | $2.5M |
| Payments Of Debt Issuance Costs | $110.0K | $1.1M | $112.3K | $501.0K |
| Proceeds From Lines Of Credit | $142.1M | $159.0M | $82.0M | $58.0M |
| Increase Decrease In Interest Reserves | -$1.3M | -$4.0M | -$793.3K | -$13.8M |
| Proceeds From Principal Repayments On Loans And Leases Held For Investment | $79.2M | $102.5M | $76.9M | $17.7M |
| Increase Decrease In Due To Related Parties Current | $171.5K | -$8.1K | $654.0K | $1.3M |
| Increase Decrease In Accounts Receivable Related Parties | -$2.2M | $3.3M | $107.2K | |
| Proceeds From Sale Of Loans Held For Investment | $0.00 | $19.0M | $13.4M | $6.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $928.7K | $881.1K | $649.3K | $845.5K | $836.3K | $531.3K | $540.4K | $263.8K | $138.3K | $84.9K | $122.5K | $120.9K | ||
| Stock Issued During Period Value Share Based Compensation | $649.3K | $845.5K | $836.3K | $531.3K | $540.4K | $263.8K | $138.3K | $95.5K | $122.7K | $121.9K | ||||
| Proceeds From Issuance Of Common Stock | $1.0M | $9.8M | $6.0M | $4.5M | $31.4M | $100.0K | ||||||||
| Net Cash Provided By Used In Financing Activities | -$29.7M | $10.8M | -$28.1M | -$30.6K | $31.4M | $100.0K | ||||||||
| Net Cash Provided By Used In Operating Activities | $7.6M | $6.9M | $1.7M | $3.0M | $1.5M | |||||||||
| Net Cash Provided By Used In Investing Activities | $5.5M | -$18.7M | $25.3M | -$77.2M | -$32.0M | |||||||||
| Increase Decrease In Accrued Interest Receivable Net | $62.1K | -$77.3K | $3.0M | $176.0K | $84.4K | |||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $255.4K | $210.6K | -$81.1K | $358.9K | -$43.5K | |||||||||
| Payments Of Stock Issuance Costs | $82.1K | $339.9K | $104.7K | $23.9K | ||||||||||
| Payments Of Dividends | $13.6M | $13.9M | $13.5M | $4.5M | ||||||||||
| Increase Decrease In Other Receivables | $116.9K | $97.2K | $19.5K | $10.1K | $118.00 | |||||||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | -$1.1M | -$1.4M | -$1.2M | -$233.6K | ||||||||||
| Payments Of Debt Issuance Costs | $0.00 | $49.7K | $3.0K | |||||||||||
| Proceeds From Lines Of Credit | $16.0M | $28.0M | $28.5M | |||||||||||
| Increase Decrease In Interest Reserves | -$771.1K | $1.4M | -$1.6M | |||||||||||
| Proceeds From Principal Repayments On Loans And Leases Held For Investment | $9.2M | $3.7M | $44.9M | |||||||||||
| Increase Decrease In Due To Related Parties Current | -$456.9K | -$296.8K | -$127.4K | |||||||||||
| Increase Decrease In Accounts Receivable Related Parties | -$2.1M | $85.1K | $237.9K | |||||||||||
| Proceeds From Sale Of Loans Held For Investment | $13.4M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 21.0M | 19.3M | 18.1M | 17.7M | |
| Weighted Average Number Of Diluted Shares Outstanding | 21.4M | 19.7M | 18.3M | 17.7M | |
| Earnings Per Share Diluted | $1.68 | $1.88 | $2.11 | $1.82 | |
| Earnings Per Share Basic | $1.71 | $1.92 | $2.14 | $1.83 | |
| Common Stock Dividends Per Share Declared | $1.88 | $2.06 | $2.17 | $2.10 | |
| Common Stock Shares Outstanding | 21.1M | 20.8M | 18.2M | 17.7M | 17.5M |
| Common Stock Shares Issued | 21.1M | 20.8M | 18.2M | 17.7M | 17.5M |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 21.1M | 21.0M | 20.9M | 19.6M | 19.4M | 18.3M | 18.2M | 18.1M | 17.9M | 17.7M | 17.7M | 17.6M | 4.9M | 2.4M | 6.4K |
| Weighted Average Number Of Diluted Shares Outstanding | 21.5M | 21.5M | 21.3M | 20.1M | 19.9M | 18.6M | 18.6M | 18.3M | 18.0M | 17.8M | 17.8M | 17.7M | 4.9M | 2.4M | 6.4K |
| Earnings Per Share Diluted | $0.42 | $0.41 | $0.47 | $0.56 | $0.46 | $0.47 | $0.54 | $0.47 | $0.60 | $0.55 | $0.42 | $0.44 | $0.83 | $0.45 | |
| Earnings Per Share Basic | $0.42 | $0.42 | $0.48 | $0.57 | $0.47 | $0.48 | $0.55 | $0.48 | $0.60 | $0.55 | $0.42 | $0.44 | $0.83 | $0.45 | |
| Common Stock Dividends Per Share Declared | $0.47 | $0.47 | $0.47 | $0.47 | $0.47 | $0.47 | $0.47 | $0.47 | $0.47 | $0.47 | $0.47 | $0.40 | |||
| Common Stock Shares Outstanding | 21.1M | 21.1M | 20.9M | 19.6M | 19.6M | 18.2M | 18.2M | 18.2M | 18.2M | 17.7M | 17.8M | 17.8M | |||
| Common Stock Shares Issued | 21.1M | 21.1M | 20.9M | 19.6M | 19.6M | 19.1M | 18.2M | 18.2M | 19.1M | 17.7M | 17.8M | 17.8M | |||
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Professional Fees | $1.9M | $1.8M | $2.2M | $2.2M |
| Stock Issued During Period Value New Issues | $872.7K | $38.4M | $1.2M | $4.5M |
| Capital Expenditures Incurred But Not Yet Paid | $11.2M | $13.6M | $13.9M | $13.6M |
| Provision For Loan Losses Expensed | $731.1K | -$583.3K | $940.4K | $3.9M |
| Noninterest Expense | $19.5M | $17.7M | $18.6M | $16.6M |
| Interest Income Operating | $62.9M | $62.1M | $62.9M | $51.5M |
| Amortization Of Financing Costs And Discounts | $406.7K | $257.0K | $550.9K | $563.5K |
| Lines Of Credit Current | $49.1M | $55.0M | $66.0M | $58.0M |
| Issuance Of And Fundings Of Loans Held For Investment | $76.0M | $155.3M | $92.2M | $149.7M |
| Repayments Of Lines Of Credit | $148.0M | $170.0M | $74.0M | |
| OID Withheld From Funding Of Loans Held For Investment | $2.1M | $1.8M | $1.3M | $3.2M |
| Interest Paid Net | $6.9M | $6.2M | $5.0M | $1.7M |
| Interest Income Operating Paid In Kind | $6.2M | $9.1M | $9.5M | $6.9M |
| Loan Held For Investment Related Party | $76.2M | $38.2M | $16.4M | |
| Stock Issued During Period Value Stock Dividend | $37.3M | |||
| Provision For Current Expected Credit Losses | $3.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Professional Fees | $530.9K | $480.1K | $492.9K | $468.7K | $409.1K | $449.9K | $491.1K | $537.9K | $569.4K | $348.8K | $743.7K | $556.9K | |
| Stock Issued During Period Value New Issues | -$68.7K | $951.4K | -$46.1K | $6.2M | $13.9M | $1.2M | $4.5M | ||||||
| Capital Expenditures Incurred But Not Yet Paid | $9.8M | $9.0M | $8.7M | $7.1M | $1.1M | ||||||||
| Provision For Loan Losses Expensed | $557.2K | $1.1M | -$1.1M | -$989.6K | -$275.5K | $380.3K | -$41.4K | $1.1M | $96.1K | $306.9K | |||
| Noninterest Expense | $4.8M | $5.7M | $3.0M | $3.2M | $4.0M | $4.5M | $3.8M | $5.0M | $4.2M | $3.2M | |||
| Interest Income Operating | $15.3M | $16.5M | $15.1M | $16.3M | $15.0M | $15.3M | $15.2M | $14.7M | $16.5M | $13.8M | |||
| Amortization Of Financing Costs And Discounts | $110.3K | $90.9K | $167.3K | $72.3K | $16.7K | ||||||||
| Lines Of Credit Current | $52.4M | $71.2M | $38.0M | $54.0M | $76.8M | $81.3M | $63.0M | $43.0M | $37.5M | $53.0M | $45.0M | ||
| Issuance Of And Fundings Of Loans Held For Investment | $3.7M | $22.4M | $32.9M | ||||||||||
| Repayments Of Lines Of Credit | $33.0M | $12.8M | $49.0M | ||||||||||
| OID Withheld From Funding Of Loans Held For Investment | $181.8K | $105.1K | $1.1M | ||||||||||
| Interest Paid Net | $1.7M | $1.8M | $1.4M | ||||||||||
| Interest Income Operating Paid In Kind | $1.6M | $3.0M | $2.3M | ||||||||||
| Loan Held For Investment Related Party | $18.9M | $40.0M | $38.5M | $16.4M | $16.4M | $16.5M | $16.3M | ||||||
| Stock Issued During Period Value Stock Dividend | $8.6M | $8.5M | $8.3M | $8.3M | $7.1M | $1.1M | |||||||
| Provision For Current Expected Credit Losses | $1.1M | $96.1K | $306.9K | $1.0M | $51.3K |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.